Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16184
Title: Randomised controlled trials of psychological & pharmacological treatments for body dysmorphic disorder: A systematic review
Austin Authors: Phillipou, Andrea ;Rossell, Susan L;Wilding, Helen E;Castle, David J
Affiliation: Austin Health, Heidelberg, Victoria, Australia
Department of Psychiatry, St Vincent's Hospital, Fitzroy, Victoria, Australia
Department of Psychiatry, The University of Melbourne, Parkville, Victoria, Australia
Department of Mental Health, Austin Health, Heidelberg, Victoria, Australia
Brain & Psychological Sciences Research Centre, Swinburne University of Technology, Hawthorn, Victoria, Australia
Monash Alfred Psychiatry Research Centre, Melbourne, Victoria, Australia
Faculty of Health Sciences, Australian Catholic University, Fitzroy, Victoria, Australia
Issue Date: Nov-2016
metadata.dc.date: 2016-08-05
Publication information: Psychiatry research 2016; 245: 179-185
Abstract: Treatment for body dysmorphic disorder (BDD) often involves a combination of psychological and pharmacological interventions. However, only a small number of randomised controlled trials (RCTs) have been undertaken examining the efficacy of different therapeutic interventions. The aim of this study was to systematically review the RCTs involving psychological and pharmacological interventions for the treatment of BDD. The literature was searched to June 2015, and studies were included if they were written in English, empirical research papers published in peer-review journals, specifically assessed BDD patients, and involved a RCT assessing BDD symptoms pre- and post-intervention. Nine studies were identified: six involving psychological and three involving pharmacological interventions. Cognitive behaviour therapy, metacognitive therapy and selective serotonin reuptake inhibitors were identified as treatments with potential benefit. The small number of RCTs and the heterogeneity of findings emphasises the need for more high quality RCTs assessing both psychological and pharmacological interventions for BDD.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16184
DOI: 10.1016/j.psychres.2016.05.062
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/27544783
Type: Journal Article
Subjects: Cognitive therapy
Body dysmorphic disorders
Behaviour therapy
Serotonin and noradrenaline reuptake inhibitors
Type of Clinical Study or Trial: Reviews/Systematic Reviews
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.